Similar Papers

Paper Title
Journal
Date
Author
The heterogeneity of markets for drugs in Europe
Gérard De Pouvourville
The European Journal of Health Economics (HEPAC) | VOL. 2
Gérard De PouvourvilleGérard De Pouvourville
01 Mar 2001
European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs
Teun Van Gelder
Transplant International | VOL. 24
Teun Van GelderTeun Van Gelder
28 Oct 2011
Ethics in clinical research
Silvio Garattini ... Vittorio Bertele’
Journal of Hepatology | VOL. 51
Silvio Garattini, et. al.Silvio Garattini ... Vittorio Bertele’
17 Jul 2009
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Rosanna Coppo ...
Kidney International | VOL. 86
Rosanna Coppo, et. al.Rosanna Coppo ...
02 Apr 2014
View more papers

More From: Pharmaceutical medicine

Paper Title
Journal
Date
Author
Pricing and Impact: Understanding Sales Trends and Price-Volume Distributions of Antihypertensive Drugs in Europe, USA, and India.
Gautam Satheesh ... Abdul Salam
Pharmaceutical medicine | VOL. -
Gautam Satheesh, et. al.Gautam Satheesh ... Abdul Salam
18 Jan 2025
Knowing is Half the Battle: The Factors Leading to Efficient Recruitment of Representative Samples in Schizophrenia Research.
Joohyun Yoon ... Joshua T Kantrowitz
Pharmaceutical medicine | VOL. -
Joohyun Yoon, et. al.Joohyun Yoon ... Joshua T Kantrowitz
11 Jan 2025
Author’s Reply to Pongpirul: “The Pharmaceutical Year that was, 2024”
Anthony W Fox
Pharmaceutical Medicine | VOL. -
Anthony W FoxAnthony W Fox
24 Dec 2024
Comment on: “The Pharmaceutical Year that was, 2024”
Krit Pongpirul
Pharmaceutical Medicine | VOL. -
Krit PongpirulKrit Pongpirul
24 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.